502
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin

, , , , , , & show all
Pages 334-342 | Received 20 May 2016, Accepted 22 Aug 2016, Published online: 25 Oct 2016

References

  • Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2012;64:302–315.
  • Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed Nanotech 2010;6:9–24.
  • Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev 2015;115:10938–10966.
  • Samad A, Sultana Y, Adil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297–305.
  • Meure LA, Foster NR, Dehghani F. Conventional and dense gas techniques for the production of liposomes: a review. AAPS Pharm Sci Tech 2008;9:798–809.
  • Allen TM, Moase EH. Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Delivery Rev 1996;21:117–133.
  • Ruysschaert T, Germain M, Fournier D, et al. Liposome-based nanocapsules. IEEE Trans Nanobioscience 2004;3:9–55.
  • Bossy-Nobs L, Buchegger F, Gurny R, Allemann E. Coupling methods to obtain ligand-targeted liposomes and nanoparticles. In: Benita S, ed. Microencapsulation. Methods and industrial applications. Drugs and pharmaceutical sciences. New York, London: Taylor and Francis Group, CRC Press; 2006:123–148.
  • Junping W, Maitani J, Takayama K, Nagai T. In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome. Int J Pharmaceutics 2000;203:61–69.
  • Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006;1:297–315.
  • Kierstead PH, Okochi H, Venditto VJ, et al. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J Control Release 2015;213:1–9.
  • Fukui Y, Fujimoto K. The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome. Langmuir 2009;25:10020–10025.
  • Cuomo F, Lopez F, Ceglie A, et al. pH-responsive liposome-templated polyelectrolyte nanocapsules. Soft Matter 2012;8:4415–4420.
  • Prabaharan M. Review paper: chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 2008;23:5–36.
  • Alsarra IA, Hamed AY, Alanazi FK. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. Drug Deliv 2008;15:313–321.
  • Mady MM, Darwish MM, Khalil S, Khalil WM. Biophysical studies on chitosan-coated liposomes. Eur Biophys J 2009;38:1127–1133.
  • Dornish M, Kaplan DS, Arepalli SR. Regulatory status of chitosan and derivatives. In: Sarmento B, das Neves J, eds. Chitosan-based systems for biopharmaceuticals: delivery, targeting and polymer therapeutics. Chichester: Wiley and Sons; 2012:463–482.
  • Qiang F, Shin H-J, Lee B-J, Han H-K. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm 2012;430:161–166.
  • Chen H, Pan H, Li P, et al. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf B Biointerfaces 2016;143:455–462.
  • Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 1996;13:896–901.
  • Guo J, Ping Q, Jiang G, et al. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm 2003;260:167–173.
  • Jiang GB, Quan D, Liao K, Wang H. Preparation of polymeric micelles based on chitosan bearing a small amount of highly hydrophobic groups. Carbohydr Polym 2006;66:514–518.
  • Mascolini M, Mellors JW, Richman DD, et al. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies. J Antiviral Therapy 2011;16:263–286.
  • Karpenko I, Deev S, Kiselev O, et al. Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication. Antimicrob Agents Chemother 2010;54:2017–2022.
  • Kiselev OI, Deeva EG, Melnikova TI, et al. A new antiviral drug Triazavirin: results of phase II clinical trial. Vopr Virusol 2012;57:9–12.
  • Loginova SI, Borisevich SV, Rusinov VL, Ulomski UN, Charushin VN, Chupakhin ON. Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture. Antibiot Khimioter 2014;59:3–5.
  • Tumashov АА, Artem’ev GА, Rusinov VL, et al. Quantitative determination of antiviral drug Triazavirin® using HPLC. Drug Dev Reg 2014;6:68–71.
  • Mironov MA, Shulepov ID, Ponomarev VS, Bakulev VA. Synthesis of polyampholyte microgels from colloidal salts of pectinic acid and their application as pH-responsive emulsifiers. Colloid Polym Sci 2013;291:1683–1691.
  • Li X, Franke AA. Improved LC-MS method for the determination of fatty acids in red blood cells by LC-orbitrap MS. Anal Chem 2011;83:3192–3198.
  • Chupakhin ON, Rusinov VL, Ulomskij EN, et al. 2-Methylthio-6-nitro-1,2,4-triazolo[5,1-C]-1,2,4-triazine-7(4H)-one sodium salt dihydrate possessing antiviral activity. Russian Federation patent RU 2,294,936 C1; 2007 Mar 10.
  • Stability Testing of New Drug Substances and Products, Q1A(R2). Step 4 version. ICH Harmonised Tripartite Guideline; 2003.
  • Kinev MY, Gavrilin MV, Melnikova OA, Petrov AY. Development method for quantative determination Triazavirin in pharmaceutical compositions for nasal spray using the method of high performance liquid chromatography. Mod Prob Sci Edu 2014;6:1788–1798.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Lasch J, Weissig V, Brandl M. Preparation of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes: a practical approach. New York: Oxford University Press; 2003:3–9.
  • Han HK, Shin HJ, Ha D. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci 2012;46:500–507.
  • Parmentier J, Hofhaus G, Thomas S, et al. Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and Omeprazole. J Pharm Sci 2014;103:3985–3993.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.